Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
BMC Bioinformatics ; 18(1): 401, 2017 Sep 07.
Artículo en Inglés | MEDLINE | ID: mdl-28882107

RESUMEN

BACKGROUND: Deep sequencing of lymphocyte receptor repertoires has made it possible to comprehensively profile the clonal composition of lymphocyte populations. This opens the door for novel approaches to diagnose and prognosticate diseases with a driving immune component by identifying repertoire sequence patterns associated with clinical phenotypes. Indeed, recent studies support the feasibility of this, demonstrating an association between repertoire-level summary statistics (e.g., diversity) and patient outcomes for several diseases. In our own prior work, we have shown that six codons in VH4-containing genes in B cells from the cerebrospinal fluid of patients with relapsing remitting multiple sclerosis (RRMS) have higher replacement mutation frequencies than observed in healthy controls or patients with other neurological diseases. However, prior methods to date have been limited to focusing on repertoire-level summary statistics, ignoring the vast amounts of information in the millions of individual immune receptors comprising a repertoire. We have developed a novel method that addresses this limitation by using innovative approaches for accommodating the extraordinary sequence diversity of immune receptors and widely used machine learning approaches. We applied our method to RRMS, an autoimmune disease that is notoriously difficult to diagnose. RESULTS: We use the biochemical features encoded by the complementarity determining region 3 of each B cell receptor heavy chain in every patient repertoire as input to a detector function, which is fit to give the correct diagnosis for each patient using maximum likelihood optimization methods. The resulting statistical classifier assigns patients to one of two diagnosis categories, RRMS or other neurological disease, with 87% accuracy by leave-one-out cross-validation on training data (N = 23) and 72% accuracy on unused data from a separate study (N = 102). CONCLUSIONS: Our method is the first to apply statistical learning to immune repertoires to aid disease diagnosis, learning repertoire-level labels from the set of individual immune repertoire sequences. This method produced a repertoire-based statistical classifier for diagnosing RRMS that provides a high degree of diagnostic capability, rivaling the accuracy of diagnosis by a clinical expert. Additionally, this method points to a diagnostic biochemical motif in the antibodies of RRMS patients, which may offer insight into the disease process.


Asunto(s)
Modelos Estadísticos , Esclerosis Múltiple Recurrente-Remitente/diagnóstico , Secuencia de Aminoácidos , Área Bajo la Curva , Linfocitos B/metabolismo , Regiones Determinantes de Complementariedad/química , Regiones Determinantes de Complementariedad/metabolismo , Secuenciación de Nucleótidos de Alto Rendimiento , Humanos , Esclerosis Múltiple Recurrente-Remitente/clasificación , Esclerosis Múltiple Recurrente-Remitente/inmunología , Enfermedades del Sistema Nervioso/clasificación , Enfermedades del Sistema Nervioso/diagnóstico , Enfermedades del Sistema Nervioso/inmunología , Curva ROC
2.
BMC Bioinformatics ; 18(1): 448, 2017 Oct 11.
Artículo en Inglés | MEDLINE | ID: mdl-29020925

RESUMEN

BACKGROUND: Pre-processing of high-throughput sequencing data for immune repertoire profiling is essential to insure high quality input for downstream analysis. VDJPipe is a flexible, high-performance tool that can perform multiple pre-processing tasks with just a single pass over the data files. RESULTS: Processing tasks provided by VDJPipe include base composition statistics calculation, read quality statistics calculation, quality filtering, homopolymer filtering, length and nucleotide filtering, paired-read merging, barcode demultiplexing, 5' and 3' PCR primer matching, and duplicate reads collapsing. VDJPipe utilizes a pipeline approach whereby multiple processing steps are performed in a sequential workflow, with the output of each step passed as input to the next step automatically. The workflow is flexible enough to handle the complex barcoding schemes used in many immunosequencing experiments. Because VDJPipe is designed for computational efficiency, we evaluated this by comparing execution times with those of pRESTO, a widely-used pre-processing tool for immune repertoire sequencing data. We found that VDJPipe requires <10% of the run time required by pRESTO. CONCLUSIONS: VDJPipe is a high-performance tool that is optimized for pre-processing large immune repertoire sequencing data sets.


Asunto(s)
Linfocitos B/metabolismo , Secuenciación de Nucleótidos de Alto Rendimiento/métodos , Inmunoglobulina G/genética , Programas Informáticos , Animales , Cartilla de ADN , Humanos , Ratones , Factores de Tiempo
3.
Acta Neuropathol ; 133(1): 43-60, 2017 01.
Artículo en Inglés | MEDLINE | ID: mdl-27730299

RESUMEN

Plasmablasts are a highly differentiated, antibody secreting B cell subset whose prevalence correlates with disease activity in Multiple Sclerosis (MS). For most patients experiencing partial transverse myelitis (PTM), plasmablasts are elevated in the blood at the first clinical presentation of disease (known as a clinically isolated syndrome or CIS). In this study we found that many of these peripheral plasmablasts are autoreactive and recognize primarily gray matter targets in brain tissue. These plasmablasts express antibodies that over-utilize immunoglobulin heavy chain V-region subgroup 4 (VH4) genes, and the highly mutated VH4+ plasmablast antibodies recognize intracellular antigens of neurons and astrocytes. Most of the autoreactive, highly mutated VH4+ plasmablast antibodies recognize only a portion of cortical neurons, indicating that the response may be specific to neuronal subgroups or layers. Furthermore, CIS-PTM patients with this plasmablast response also exhibit modest reactivity toward neuroantigens in the plasma IgG antibody pool. Taken together, these data indicate that expanded VH4+ peripheral plasmablasts in early MS patients recognize brain gray matter antigens. Peripheral plasmablasts may be participating in the autoimmune response associated with MS, and provide an interesting avenue for investigating the expansion of autoreactive B cells at the time of the first documented clinical event.


Asunto(s)
Autoanticuerpos/metabolismo , Linfocitos B/inmunología , Encéfalo/inmunología , Esclerosis Múltiple/inmunología , Células Plasmáticas/inmunología , Adulto , Anciano , Astrocitos/inmunología , Astrocitos/patología , Linfocitos B/patología , Encéfalo/patología , Encefalomielitis Autoinmune Experimental/inmunología , Encefalomielitis Autoinmune Experimental/patología , Femenino , Sustancia Gris/inmunología , Sustancia Gris/patología , Humanos , Inmunoglobulina G/metabolismo , Masculino , Persona de Mediana Edad , Esclerosis Múltiple/patología , Neuromielitis Óptica/inmunología , Neuromielitis Óptica/patología , Neuronas/inmunología , Neuronas/patología , Células Plasmáticas/fisiología , Accidente Cerebrovascular/inmunología , Accidente Cerebrovascular/patología , Adulto Joven
4.
Front Immunol ; 9: 976, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29867956

RESUMEN

Background: Recent technological advances in immune repertoire sequencing have created tremendous potential for advancing our understanding of adaptive immune response dynamics in various states of health and disease. Immune repertoire sequencing produces large, highly complex data sets, however, which require specialized methods and software tools for their effective analysis and interpretation. Results: VDJServer is a cloud-based analysis portal for immune repertoire sequence data that provide access to a suite of tools for a complete analysis workflow, including modules for preprocessing and quality control of sequence reads, V(D)J gene segment assignment, repertoire characterization, and repertoire comparison. VDJServer also provides sophisticated visualizations for exploratory analysis. It is accessible through a standard web browser via a graphical user interface designed for use by immunologists, clinicians, and bioinformatics researchers. VDJServer provides a data commons for public sharing of repertoire sequencing data, as well as private sharing of data between users. We describe the main functionality and architecture of VDJServer and demonstrate its capabilities with use cases from cancer immunology and autoimmunity. Conclusion: VDJServer provides a complete analysis suite for human and mouse T-cell and B-cell receptor repertoire sequencing data. The combination of its user-friendly interface and high-performance computing allows large immune repertoire sequencing projects to be analyzed with no programming or software installation required. VDJServer is a web-accessible cloud platform that provides access through a graphical user interface to a data management infrastructure, a collection of analysis tools covering all steps in an analysis, and an infrastructure for sharing data along with workflows, results, and computational provenance. VDJServer is a free, publicly available, and open-source licensed resource.


Asunto(s)
Nube Computacional , Biología Computacional/métodos , Genómica/métodos , Exones VDJ/inmunología , Animales , Metodologías Computacionales , Humanos , Difusión de la Información , Ratones , Programas Informáticos , Interfaz Usuario-Computador , Navegador Web , Flujo de Trabajo
5.
Gene ; 572(2): 191-7, 2015 Nov 10.
Artículo en Inglés | MEDLINE | ID: mdl-26172868

RESUMEN

BACKGROUND: We have previously demonstrated that cerebrospinal fluid-derived B cells from early relapsing-remitting multiple sclerosis (RRMS) patients that express a VH4 gene accumulate specific replacement mutations. These mutations can be quantified as a score that identifies such patients as having or likely to convert to RRMS. Furthermore, we showed that next generation sequencing is an efficient method for obtaining the sequencing information required by this mutation scoring tool, originally developed using the less clinically viable single-cell Sanger sequencing. OBJECTIVE: To determine the accuracy of MSPrecise, the diagnostic test that identifies the presence of the RRMS-enriched mutation pattern from patient cerebrospinal fluid B cells. METHODS: Cerebrospinal fluid cell pellets were obtained from RRMS and other neurological disease (OND) patient cohorts. VH4 gene segments were amplified, sequenced by next generation sequencing and analyzed for mutation score. RESULTS: The diagnostic test showed a sensitivity of 75% on the RRMS cohort and a specificity of 88% on the OND cohort. The accuracy of the test in identifying RRMS patients or patients that will develop RRMS is 84%. CONCLUSION: MSPrecise exhibits good performance in identifying patients with RRMS irrespective of time with RRMS.


Asunto(s)
Análisis Mutacional de ADN/métodos , Secuenciación de Nucleótidos de Alto Rendimiento/métodos , Cadenas Pesadas de Inmunoglobulina/genética , Técnicas de Diagnóstico Molecular/métodos , Esclerosis Múltiple Recurrente-Remitente/diagnóstico , Adulto , Femenino , Humanos , Masculino , Persona de Mediana Edad , Familia de Multigenes , Esclerosis Múltiple Recurrente-Remitente/líquido cefalorraquídeo , Esclerosis Múltiple Recurrente-Remitente/genética , Sensibilidad y Especificidad , Adulto Joven
6.
ASN Neuro ; 7(5)2015.
Artículo en Inglés | MEDLINE | ID: mdl-26489686

RESUMEN

*These authors contributed equally to the work in this manuscript.We have previously identified a distinct class of antibodies expressed by B cells in the cerebrospinal fluid (CSF) of early and established relapsing remitting multiple sclerosis (RRMS) patients that is not observed in healthy donors. These antibodies contain a unique pattern of mutations in six codons along VH4 antibody genes that we termed the antibody gene signature (AGS). In fact, patients who have such B cells in their CSF are identified as either having RRMS or developing RRMS in the future. As mutations in antibody genes increase antibody affinity for particular antigens, the goal for this study was to investigate whether AGS(+) antibodies bind to brain tissue antigens. Single B cells were isolated from the CSF of 10 patients with early or established RRMS. We chose 32 of these B cells that expressed antibodies enriched for the AGS for further study. We generated monoclonal full-length recombinant human antibodies (rhAbs) and used both immunological assays and immunohistochemistry to investigate the capacity of these AGS(+) rhAbs to bind brain tissue antigens. AGS(+) rhAbs did not recognize myelin tracts in the corpus callosum. Instead, AGS(+) rhAbs recognized neuronal nuclei and/or astrocytes, which are prevalent in the cortical gray matter. This pattern was unique to the AGS(+) antibodies from early and established RRMS patients, as AGS(+) antibodies from an early neuromyelitis optica patient did not display the same reactivity. Prevalence of CSF-derived B cells expressing AGS(+) antibodies that bind to these cell types may be an indicator of gray matter-directed autoimmunity in early and established RRMS patients.


Asunto(s)
Autoanticuerpos/inmunología , Autoanticuerpos/metabolismo , Autoinmunidad/fisiología , Linfocitos B/inmunología , Encéfalo/inmunología , Sustancia Gris/inmunología , Esclerosis Múltiple Recurrente-Remitente/inmunología , Adulto , Animales , Autoanticuerpos/genética , Encefalomielitis Autoinmune Experimental/inmunología , Femenino , Glicoproteínas/genética , Glicoproteínas/metabolismo , Células HeLa , Humanos , Masculino , Ratones , Ratones Transgénicos , Persona de Mediana Edad , Esclerosis Múltiple Recurrente-Remitente/líquido cefalorraquídeo , Oligodendroglía/inmunología , Oligodendroglía/metabolismo , Proteínas Recombinantes/metabolismo , Accidente Cerebrovascular/inmunología , Adulto Joven
7.
Front Neurol ; 5: 166, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-25278930

RESUMEN

We previously identified a distinct mutation pattern in the antibody genes of B cells isolated from cerebrospinal fluid (CSF) that can identify patients who have relapsing-remitting multiple sclerosis (RRMS) and patients with clinically isolated syndromes who will convert to RRMS. This antibody gene signature (AGS) was developed using Sanger sequencing of single B cells. While potentially helpful to patients, Sanger sequencing is not an assay that can be practically deployed in clinical settings. In order to provide AGS evaluations to patients as part of their diagnostic workup, we developed protocols to generate AGS scores using next-generation DNA sequencing (NGS) on CSF-derived cell pellets without the need to isolate single cells. This approach has the potential to increase the coverage of the B-cell population being analyzed, reduce the time needed to generate AGS scores, and may improve the overall performance of the AGS approach as a diagnostic test in the future. However, no investigations have focused on whether NGS-based repertoires will properly reflect antibody gene frequencies and somatic hypermutation patterns defined by Sanger sequencing. To address this issue, we isolated paired CSF samples from eight patients who either had MS or were at risk to develop MS. Here, we present data that antibody gene frequencies and somatic hypermutation patterns are similar in Sanger and NGS-based antibody repertoires from these paired CSF samples. In addition, AGS scores derived from the NGS database correctly identified the patients who initially had or subsequently converted to RRMS, with precision similar to that of the Sanger sequencing approach. Further investigation of the utility of the AGS in predicting conversion to MS using NGS-derived antibody repertoires in a larger cohort of patients is warranted.

8.
J Cereb Blood Flow Metab ; 34(1): 30-3, 2014 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-24149932

RESUMEN

Alzheimer's disease (AD) is a progressive, neurodegenerative disease that may involve inflammatory responses in the central nervous system (CNS). Our objective was to determine whether patients with amnestic mild cognitive impairment (aMCI), a preclinical stage of AD, have inflammatory characteristics similar to patients with multiple sclerosis (MS), a known CNS inflammatory disease. The frequency of lymphocytes and levels of pro-inflammatory cytokines in the cerebrospinal fluid of aMCI patients was comparable to MS patients or patients at high risk to develop MS. Thus, brain inflammation occurs early at the preclinical stage of AD and may have an important role in pathology.


Asunto(s)
Enfermedad de Alzheimer/inmunología , Disfunción Cognitiva/inmunología , Citocinas/líquido cefalorraquídeo , Enfermedades Desmielinizantes/inmunología , Esclerosis Múltiple/inmunología , Anciano , Enfermedad de Alzheimer/líquido cefalorraquídeo , Estudios de Casos y Controles , Linaje de la Célula , Disfunción Cognitiva/líquido cefalorraquídeo , Citocinas/inmunología , Enfermedades Desmielinizantes/líquido cefalorraquídeo , Humanos , Linfocitos/citología , Linfocitos/inmunología , Persona de Mediana Edad , Esclerosis Múltiple/líquido cefalorraquídeo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA